CONCERT PHARMACEUTICALS INC's ticker is CNCE and the CUSIP is 206022105. A total of 114 filers reported holding CONCERT PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is 3.29 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $707,000 | -27.0% | 41,982 | -0.7% | 0.05% | -30.1% |
| Q1 2018 | $968,000 | -87.2% | 42,269 | -85.5% | 0.07% | -86.8% |
| Q4 2017 | $7,554,000 | +5579.7% | 292,010 | +2352.0% | 0.56% | +6066.7% |
| Q2 2016 | $133,000 | -52.7% | 11,909 | -42.2% | 0.01% | -52.6% |
| Q1 2016 | $281,000 | -90.0% | 20,600 | -86.2% | 0.02% | -90.6% |
| Q4 2015 | $2,823,000 | -36.4% | 148,835 | -37.1% | 0.20% | -35.6% |
| Q3 2015 | $4,439,000 | +192.6% | 236,517 | +107.7% | 0.32% | +211.9% |
| Q4 2014 | $1,517,000 | – | 113,894 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 3,135,289 | $46,246,000 | 5.88% |
| GREAT POINT PARTNERS LLC | 2,006,211 | $29,592,000 | 5.76% |
| Lyon Street Capital, LLC | 463,064 | $6,830,000 | 2.63% |
| SENZAR ASSET MANAGEMENT, LLC | 335,445 | $4,948,000 | 1.21% |
| INGALLS & SNYDER LLC | 1,209,062 | $17,834,000 | 0.93% |
| Senvest Management, LLC | 314,629 | $4,641,000 | 0.31% |
| KNOTT DAVID M | 45,000 | $664,000 | 0.28% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 262,569 | $3,873,000 | 0.15% |
| PRINCETON CAPITAL MANAGEMENT INC | 14,607 | $215,000 | 0.11% |
| Manchester Capital Management LLC | 19,984 | $295,000 | 0.05% |